Jonathan D Mahnken
Overview
Explore the profile of Jonathan D Mahnken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
1848
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmadnezhad P, Burns J, Akinwuntan A, Ranchet M, Kondyli A, Babulal G, et al.
J Appl Gerontol
. 2025 Feb;
:7334648251318431.
PMID: 40009053
Driving reaction time (DRT) is one of the most important predictors of motor vehicle crashes in older adults. Although individuals with preclinical Alzheimer's disease (AD) show subtle cognitive changes that...
2.
Blankenship A, Kemna R, Kueck P, John C, Vitztum M, Yoksh L, et al.
J Appl Physiol (1985)
. 2025 Jan;
138(3):720-730.
PMID: 39829076
Impaired glycemic control increases the risk of type 2 diabetes (T2D) and Alzheimer's disease (AD). Heat therapy (HT), via hot water immersion (HWI), has shown promise in improving shared mechanisms...
3.
Green Z, John C, Kueck P, Blankenship A, Kemna R, Johnson C, et al.
J Physiol
. 2024 Sep;
PMID: 39258961
There is evidence that aerobic exercise improves brain health. Benefits may be modulated by acute physiological responses to exercise, but this has not been well characterized in older or cognitively...
4.
Kemna R, Kueck P, Blankenship A, John C, Johnson C, Green Z, et al.
Contemp Clin Trials
. 2024 Sep;
146:107682.
PMID: 39236780
Background: There is evidence that chronic exercise can benefit the brain, but the effects vary markedly between studies. One potential mechanism for exercise-related benefit is the increase in systemic lactate...
5.
Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant
Blankenship A, Yoksh L, Kueck P, Mahnken J, Morris J, Gupta A
Alzheimers Dement (Amst)
. 2024 Jul;
16(3):e12614.
PMID: 38966621
Introduction: Alzheimer's disease (AD) blood biomarkers show promise for clinical diagnosis but their reliability in chronic kidney disease (CKD) is debated. This study investigates the impact of kidney transplant (KT)...
6.
Tedaldi E, Hou Q, Armon C, Mahnken J, Palella F F, Simoncini G, et al.
J Investig Med
. 2024 Apr;
72(7):661-673.
PMID: 38666457
This article aimed at analyzing the acute impact and the longer-term recovery of COVID-19 pandemic effects on clinical encounter types, HIV viral load (VL) testing, and suppression (HIV VL < ...
7.
Gupta A, Mahnken J, Bernal J, Sharma P, Lepping R, Montgomery R, et al.
Am J Kidney Dis
. 2024 Feb;
84(1):28-37.e1.
PMID: 38423160
Rationale & Objective: Kidney disease negatively affects cognition. We assessed the effect of kidney transplantation (KT) on different cognitive domains. Study Design: Prospective cohort study. Setting & Participants: We examined...
8.
Brake A, Heskett C, Alam N, Fry L, Le K, Mahnken J, et al.
Interv Neuroradiol
. 2024 Jan;
:15910199241226470.
PMID: 38204180
Background: Intracranial atherosclerotic disease (ICAD) is a major cause of stroke with a high rate of re-occlusion following mechanical thrombectomy (MT). Among the available rescue options, glycoprotein IIb/IIIa inhibitors (GPI)...
9.
Li J, Agbobli-Nuwoaty S, Palella F, Novak R, Tedaldi E, Mayer C, et al.
AIDS Res Treat
. 2023 Dec;
2023:4423132.
PMID: 38078054
Current U.S. guidelines recommend integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) as initial treatment for people with HIV (PWH). We assessed long-term effects of INSTI use on lipid profiles...
10.
Ahmadnezhad P, Burns J, Akinwuntan A, Ranchet M, Kondyli A, Mahnken J, et al.
Gerontology
. 2023 Aug;
69(11):1307-1314.
PMID: 37557082
Introduction: Older adults with preclinical Alzheimer's disease (AD) show changes in on-road driving performance. The impact of preclinical AD on using automated vehicle (AV) technology is unknown. The aim was...